Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDistrib. Fin. Regulatory News (DFCH)

Share Price Information for Distrib. Fin. (DFCH)

Share Price is delayed by 15 minutes
Get Live Data
65.50    6.00 (10.08%)
Bid:
64.00
Ask:
67.00
Spread: 3.00 (4.688%)
Market Cap: £107.48m
DFCH Live PriceLast checked at - London Stock Exchange

Intraday Distrib. Fin. Share Chart

Board Update and Directorate Changes

13 May 2020 07:00

RNS Number : 6974M
Distribution Finance Cap. Hldgs PLC
13 May 2020
Β 

13Β May 2020

Distribution Finance Capital Holdings plcΒ ("DFC" or the "Company" or together with its subsidiaries the "DFC Group")

Board Update and Directorate Changes

The Company has relationship agreements in place with its two largest shareholders,Β Arrowgrass Master Fund Limited (AMFL) and Watrium AS. In line with market practice for such agreements, and as described in the Company's AIM Admission Document, both shareholders are entitled to appoint representative directors to the Board for as long as their shareholdings exceed agreed percentage thresholds.

As envisaged by these relationship agreements, both AMFL and Watrium AS recently informed the Company that they wished to appoint representative directors. The Board is therefore pleased to announce the appointment of Mr Stephen Greene (on behalf of AMFL) and Mr Haakon Stenrod (on behalf of Watrium AS) as Non-Executive Directors, with effect from today.

Mr Greene has investment banking, investing and capital markets experience, previously holding positions at Keel Harbour Capital Limited, Arrowgrass Capital Partners, RMG Wealth Management, ACPI Investments and Deutsche Bank. Recently he has transitioned into more technology focused roles, specifically within financial services and artificial intelligence, and currently serves as Managing Director of Orsus Ventures Limited and Coleura Labs Limited and formerly served as Managing Director of Satalia. Mr Greene has a Money, Banking and Finance degree from the University of Birmingham and is a Chartered Financial Analyst (CFA) charterholder.

Mr Stenrod is an Investment Director at Watrium AS. He was previously a partner with the leading Nordic investment banking group ABG Sundal Collier. He has broad transaction experience in M&A, equity capital markets, debt and restructuring advisory. He holds an M.Sc. in Industrial Economics and Technology Management from the Norwegian University of Science and Technology.

The Company also announces that Henry Kenner and James van den Bergh will be stepping down from the Board with immediate effect. Henry has been involved with DFC since its inception and has played an important part in the execution of the Company's strategy during that time. Alongside Henry, James joined the Board of DFC as a non-executive Director in the run-up to IPO in May 2019 to assist the Company as it transitioned from being a subsidiary of TruFin PLC to an independent company admitted to AIM. Henry is Chairman and James is CEO of TruFin plc and both remain shareholders of DFC.

Chairman John Baines commented:

"The entire firm is grateful to Henry and James for their support and advocacy of DF Capital. Without their enthusiasm and belief in the founders' vision much of what has been achieved by the company would not have been possible. Both have proven exceptional board colleagues and their wise counsel and experience has been valued by the entire board. Specifically, in relation to Henry, we appreciate him stepping in as Interim CEO last year and ensuring strategic momentum was not lost whilst we recruited a new permanent CEO and continued to progress the banking licence application. We wish both Henry and James well in their other commercial engagements beyond DFC.

The Board is delighted to welcome Stephen and Haakon as Non-Executive Directors and looks forward to working with them in supporting DFC's strategic ambitions."

Additional information required to be disclosed under Schedule Two of the AIM Rules:

Mr Greene, agedΒ 43, currently holds or has held the following directorships and partnerships over the last five years:

Current:

Past:

Trufin plc.

Keel Harbour

Orsus Ventures Limited

Capital Limited

Coleura Labs Limited

Mr Greene currently has no shares in the Company in a personal capacity. AMFL owns 52,448,082 shares or 49.2% of the Company.

Mr Stenrod, agedΒ 39, has no directorships and partnerships over the last five years to disclose under Schedule Two of the AIM Rules and currently has no shares in the Company in a personal capacity. His employer, Watrium AS, owns 14,833,922 shares or 13.9% of the Company.

Except as disclosed in this announcement, no other disclosures are required in respect of the appointment of Mr Greene or Mr Stenrod under paragraph (g) of Schedule Two of the AIM Rules for Companies.

For further information, please contact:

Enquiries:

Β 

Distribution Finance Capital Holdings plc

Carl D'Ammassa - Chief Executive Officer +44 (0) 20 3937 6390

http://www.dfcapital-investors.com

Macquarie Capital (Europe) Limited (NOMAD and broker)

Alex Reynolds +44 (0) 20 3037 2000

Jonny Allison

Blue Pool Communications (Financial PR)

Nick Lord +44 (0) 7501 271 083

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
BOABCGDUGXBDGGD
Date   Source Headline
3rd Apr 20257:00 amRNSAppointment of Chief Financial Officer Designate
2nd Apr 20257:01 amRNSTransaction in Own Shares
2nd Apr 20257:00 amRNSFinal Results
1st Apr 20257:00 amRNSTotal Voting Rights
31st Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20253:00 pmRNSNotice of Full Year Results and Presentations
19th Mar 20251:20 pmRNSHolding(s) in Company
18th Mar 20252:15 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20254:26 pmRNSHolding(s) in Company
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20254:07 pmRNSHolding(s) in Company
13th Mar 20252:49 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSHolding(s) in Company
12th Mar 202510:27 amRNSHolding(s) in Company
11th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20252:31 pmRNSHolding(s) in Company
5th Mar 202510:12 amRNSHolding(s) in Company
3rd Mar 20257:01 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20254:17 pmRNSHolding(s) in Company
20th Feb 20252:13 pmRNSHolding(s) in Company
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 202511:12 amRNSHolding(s) in Company
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSAuthorisation to conduct consumer lending
13th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20257:01 amRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 202512:39 pmRNSHolding(s) in Company
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20254:31 pmRNSHolding(s) in Company
24th Jan 20257:00 amRNSTransaction in Own Shares
22nd Jan 20257:00 amRNSTransaction in Own Shares
21st Jan 20257:00 amRNSTransaction in Own Shares
20th Jan 20257:00 amRNSTransaction in Own Shares
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:01 amRNSShare Buyback Programme
16th Jan 20257:00 amRNSTrading Update
14th Jan 20255:57 pmRNSHolding(s) in Company
10th Dec 202411:38 amRNSHolding(s) in Company
9th Dec 20241:31 pmRNSHolding(s) in Company
6th Dec 20247:00 amRNSTrading Update
15th Nov 20244:24 pmRNSHolding(s) in Company
1st Nov 20244:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.